Kevin Tan Insider Profile
4 Followers
Kevin Tan, CFO at Cartesian Therapeutics, holds 99.42K shares in Solid Biosciences (Ticker: SLDB), holds 77.00K shares in Cartesian Therapeutics (Ticker: RNAC).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-44.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kevin Tan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kevin Tan
Kevin Tan's Trading History
Cartesian Therapeutics
Jan 05, 2022
CFO
Uninformative Buy
―
$519.75K
Solid Biosciences
Feb 18, 2026
CFO & Treasurer
Uninformative Buy
32.32K
$787.42K
List of latest transactions for each holding click on a transaction to see Kevin Tan's performance on stock
You May Also Like
Kevin Tan insider profile FAQ
What is the percentage of profitable transactions made by Kevin Tan?
The percentage of profitable transactions made by Kevin Tan is 0%.
What is the average return per transaction made by Kevin Tan?
The average return per transaction made by Kevin Tan is -44.00%.
What stocks does Kevin Tan hold?
Kevin Tan holds: RNAC, SLDB stocks.
What was Kevin Tan’s latest transaction?
Kevin Tan latest transaction was an Uninformative Buy of $32.32K.
What was Kevin Tan's most profitable transaction?
Kevin Tan’s most profitable transaction was an Informative Sell of SLDB stock on February 6, 2026. The return on the trade was -32.30%.
What is Kevin Tan's role in Cartesian Therapeutics?
Kevin Tan's role in Cartesian Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.